Dr. Bahary is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
320 East North Avenue
Room O242H
Pittsburgh, PA 15212Phone+1 412-359-6391- Is this information wrong?
Summary
- Dr. Nathan Bahary is an oncologist in Pittsburgh, PA. He received his medical degree from Weill Cornell Medicine and has been in practice 28 years. He specializes in gastrointestinal cancer and is experienced in gastrointestinal oncology, general medical oncology, and pancreatic neoplasms.
Education & Training
- Dana-Farber Cancer InstituteMedical Oncology, 1997 - 2002
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1995 - 1998
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1992 - 1995
- Rockefeller UniversityPhD, Molecular Genetics, 1987 - 1992
- Weill Cornell MedicineClass of 1989
Certifications & Licensure
- WV State Medical License 2022 - 2024
- OH State Medical License 2022 - 2024
- NY State Medical License 2022 - 2024
- PA State Medical License 2002 - 2024
- MA State Medical License 1994 - 2003
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers Start of enrollment: 2005 Apr 01
- Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal Cancer Start of enrollment: 2005 Jan 01
- Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy Start of enrollment: 2006 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer.Murray, J., Sivapalan, L., Hummelink, K., Balan, A., White, J., Niknafs, N., Rhymee, L., Pereira, G., Rao, N., Weksler, B., Bahary, N., Phallen, J., Leal, A., Bartlett...> ;Clinical Cancer Research. 2024 Jan 17
- Impact of Recombinant Granulocyte Colony-Stimulating Factor During Neoadjuvant Therapy on Outcomes of Resected Pancreatic Cancer.Murthy, P., Zenati, M., AlMasri, S., DeSilva, A., Singhi, A., Paniccia, A., Lee, K., Simmons, R., Bahary, N., Lotze, M., Zureikat, A.> ;Journal of the National Comprehensive Cancer Network. 2023 Dec 27
- ASO Visual Abstract: Defining the Values and Quality of Life of Cancer Survivors Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Inte...Chelsea M Knotts, Mayar A Osman, Aderinsola A Aderonmu, Nathan Bahary, Patrick L Wagner, David L Bartlett, Casey J Allen> ;Annals of Surgical Oncology. 2023 Nov 1
- Join now to see all
Press Mentions
- National Drug Shortage Impacting Cancer Care at UPMCMay 25th, 2023
- Despite Challenging Statistics, ‘Jeopardy!’ Host Alex Trebek Vows to Fight Pancreatic CancerMarch 7th, 2019
- Genomics Could Better Match Treatments to Pancreatic Cancer PatientsMarch 4th, 2019
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: